doi:10.19983/j.issn.2096-8493.20260136

Abstract

CLC Number:

References 8

[1]	中华医学会, 中华医学会杂志社, 中华医学会全科医学分会, 等. 中国咳嗽基层诊疗与管理指南(2024年)[J]. 中华全科医师杂志, 2024, 23 (8): 793-812. doi:10.3760/cma.j.cn114798-20240326-00177.
[2]	Simons D G, Travell J G, Simons L S. Travell, Simons & Simons’ Myofascial Pain and Dysfunction: The Trigger Point Manual[M]. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 2019.
[3]	符仲华. 浮针医学纲要[M]. 北京: 人民卫生出版社, 2016.
[4]	陈红根. 浮针疗法治疗干咳20例疗效观察[J]. 内蒙古中医药, 2014, 33(30): 78-79. doi:10.3969/j.issn.1006-0979.2014.30.087.
[5]	张玉, 周胜红. 浮针疗法治疗呼吸系统疾病浅析[J]. 河南中医, 2023, 43(5): 777-782. doi:10.16367/j.issn.1003-5028.2023.05.0158.
[6]	吕中广. 浮针治疗慢性咳嗽20例[J]. 中国针灸, 2010, 30(1): 22. doi:10.13703/j.0255-2930.2010.01.013.
[7]	周雪, 陆瑾, 符仲华, 等. 浮针治疗慢性阻塞性肺疾病急性加重期20例[J]. 中国针灸, 2013, 33(6):527-528. doi:10.13703/j.0255-2930.2013.06.017.
[8]	刘广恒. 肌筋膜扳机点注射法治疗咳嗽变异性哮喘[D]. 济南: 山东大学, 2020. doi:10.27272/d.cnki.gshdu.2020.002714.

[1]	Ma Zhiming. Interpretation of Chinese Expert Consensus on Diagnosis and Treatment of Pneumoconiosis Complicated with Pulmonary Tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2026, 7(5): 559-563.
[2]	Nie Ligang, Zhang Mingyue, Amina·Mamuti , Wang Xueyu, Lu Shuihua, Nie Wenjuan. Study design of a single-arm feasibility trial of the ultra-short-course B-P-L-S-Z regimen for rifampicin-resistant tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2026, 7(5): 568-573.
[3]	Zeng Chunmei, Lu Qingxia, Nie Wenjuan, Zhu Qingdong, Chu Naihui, Zhu Fengmei. A phase Ⅱ clinical study on the early bactericidal activity, safety, and tolerability of oral sudapyridine (WX-081) tablets in patients with newly diagnosed drug-susceptible and drug-resistant pulmonary tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2026, 7(5): 574-580.
[4]	Yi Benju, Tang Yuhong, Mo Yixin, Jiang Lina, Liao Yi. Analysis of tuberculosis infection and associated factors among household close contacts of active pulmonary tuberculosis patients in Hechuan District, Chongqing City [J]. Journal of Tuberculosis and Lung Disease, 2026, 7(5): 581-588.
[5]	Pang Yan, Wu Chengguo, Wang Qingya, Peng Peng. Analysis of the factors influencing medication adherence among pulmonary tuberculosis patients in Chongqing City from 2021 to 2024 [J]. Journal of Tuberculosis and Lung Disease, 2026, 7(5): 589-595.
[6]	Li Yingying, Ren Yan. Research progress on adrenal insufficiency associated with adrenal tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2026, 7(5): 665-672.
[7]	Pan Lihua, Zhan Lu. Clinical value and research progress of urinary lipoarabinomannan detection in the diagnosis of pediatric tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2026, 7(5): 673-678.
[8]	Jiang Ping, Li Tianju, Kang Guanghong, Xiang Mingque. Research progress on prevention and control strategies for latent Mycobacterium tuberculosis infection [J]. Journal of Tuberculosis and Lung Disease, 2026, 7(5): 679-686.
[9]	Zhang Yuhao, Wang Dan, Wang Shuhan, Li Chen, Zheng Chanjuan, Tang Wenjie, Yang Yide, Gong Fanghua. Mobile health technology for improving treatment adherence in tuberculosis patients: a review [J]. Journal of Tuberculosis and Lung Disease, 2026, 7(5): 687-693.
[10]	. [J]. Journal of Tuberculosis and Lung Disease, 2026, 7(5): 708-711.
[11]	. [J]. Journal of Tuberculosis and Lung Disease, 2026, 7(4): 539-540.
[12]	. [J]. Journal of Tuberculosis and Lung Disease, 2026, 7(4): 534-538.
[13]	Yuan Jingsong, Lin Yi, Deng Guofang, Chen Jingfang, Meng Ting, Wu Yuanling. Research progress on caregiver burden and intervention strategies for patients with tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2026, 7(4): 520-525.
[14]	Yang Yan, Chen Siying, Yang Xuejuan, Na Hong, Deng Fumei, Wang Haiyan. Visualization analysis of tuberculosis nutrition research based on CiteSpace [J]. Journal of Tuberculosis and Lung Disease, 2026, 7(4): 493-501.
[15]	Zhang Yaxi, Yu Hong, Li Jing, Gou Jizhou, Yang Qianting, Zhan Senlin, Chen Qi. Diagnostic value of combining HE staining with three pathogen detection methods in tuberculosis histopathology for improving the positivity rate of active tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2026, 7(4): 487-492.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 8

Related Articles 15

Recommended Articles

Metrics

Comments